In addition, several studies have reported a negative impact of YAP1 activation on the survival of patients with gastric, colorectal, ovarian, bladder, and non-small cell lung cancer (22, 29, 35–37). The gene discussed is YAP1; the disease is non-small cell lung carcinoma.